Literature DB >> 22997242

Human gastric TFF2 peptide contains an N-linked fucosylated N,N'-diacetyllactosediamine (LacdiNAc) oligosaccharide.

Franz-Georg Hanisch1, Hubert Ragge, Thomas Kalinski, Frank Meyer, Hubert Kalbacher, Werner Hoffmann.   

Abstract

In the human stomach, the peptide trefoil factor family 2 (TFF2) is secreted together with the mucin MUC6 by mucous neck cells (MNCs) and antral gland cells. TFF2 is strongly associated with the gastric mucus and promotes gastric restitution. Here, TFF2 was purified from the human corpus and antrum, respectively, by size-exclusion chromatography, and the N-linked glycan structure at N-15 of the mature peptide was determined. As a hallmark, the unusual monofucosylated N,N'-diacetylhexosediamine (tentatively assigned as GalNAcβ1 → 4GlcNAc, LacdiNAc) modification was detected as the terminal structure of a bi-antennary complex type N-glycan exhibiting also core fucosylation. Replicate analyses did not show microheterogeneities in the fraction of peptide-N-glycosidase F cleaved and permethylated N-glycans when analyzed by matrix-assisted laser desorption ionization (MALDI) mass spectrometry (MS). On the glycopeptide level, a minor glycan microheterogeneity was evident in liquid chromatography-electrospray ionization (ESI)-MS, demonstrating the presence of underfucosylated species. The tryptic TFF2 N-glycopeptide p34-39 (LSPHNR N-glycosylated with Fuc3Hex3HexNAc6) was identified by both ESI-tandem mass spectrometry and MALDI-post-source decay analysis. Lectin analyses with the Wisteria floribunda agglutinin indicated the potential presence of LacdiNAc terminating glycans and revealed minor differences between TFF2 from fundic units, i.e. MNCs, and antral units, i.e. antral gland cells. Strikingly, on the level of the primary structure, there was no indication that the formation of the proposed LacdiNAc structure is cis-controlled by a peptidic determinant related to the published sequences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22997242     DOI: 10.1093/glycob/cws131

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  15 in total

1.  Human trefoil factor 2 is a lectin that binds α-GlcNAc-capped mucin glycans with antibiotic activity against Helicobacter pylori.

Authors:  Franz-Georg Hanisch; David Bonar; Nils Schloerer; Horst Schroten
Journal:  J Biol Chem       Date:  2014-08-14       Impact factor: 5.157

Review 2.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

3.  Trefoil factor family domains represent highly efficient conformational determinants for N-linked N,N'-di-N-acetyllactosediamine (LacdiNAc) synthesis.

Authors:  David Bonar; Franz-Georg Hanisch
Journal:  J Biol Chem       Date:  2014-09-10       Impact factor: 5.157

4.  Chemical synthesis of human trefoil factor 1 (TFF1) and its homodimer provides novel insights into their mechanisms of action.

Authors:  Nayara Braga Emidio; Hayeon Baik; David Lee; René Stürmer; Jörn Heuer; Alysha G Elliott; Mark A T Blaskovich; Katharina Haupenthal; Nicole Tegtmeyer; Werner Hoffmann; Christina I Schroeder; Markus Muttenthaler
Journal:  Chem Commun (Camb)       Date:  2020-05-11       Impact factor: 6.222

5.  Epithelial Regeneration After Gastric Ulceration Causes Prolonged Cell-Type Alterations.

Authors:  Eitaro Aihara; Andrea L Matthis; Rebekah A Karns; Kristen A Engevik; Peihua Jiang; Jiang Wang; Bruce R Yacyshyn; Marshall H Montrose
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-05-17

Review 6.  Trefoil Factor Family (TFF) Peptides and Their Diverse Molecular Functions in Mucus Barrier Protection and More: Changing the Paradigm.

Authors:  Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

Review 7.  Trefoil Factor Family (TFF) Peptides and Their Links to Inflammation: A Re-evaluation and New Medical Perspectives.

Authors:  Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

8.  A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG).

Authors:  George Pentheroudakis; Vassiliki Kotoula; Elena Fountzilas; George Kouvatseas; George Basdanis; Ioannis Xanthakis; Thomas Makatsoris; Elpida Charalambous; Demetris Papamichael; Epaminontas Samantas; Pavlos Papakostas; Dimitrios Bafaloukos; Evangelia Razis; Christos Christodoulou; Ioannis Varthalitis; Nicholas Pavlidis; George Fountzilas
Journal:  BMC Cancer       Date:  2014-02-20       Impact factor: 4.430

9.  Terminal N-acetylgalactosamine-specific leguminous lectin from Wisteria japonica as a probe for human lung squamous cell carcinoma.

Authors:  Keisuke Soga; Futaba Teruya; Hiroaki Tateno; Jun Hirabayashi; Kazuo Yamamoto
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

Review 10.  The Double Face of Mucin-Type O-Glycans in Lectin-Mediated Infection and Immunity.

Authors:  Vasily Morozov; Julia Borkowski; Franz-Georg Hanisch
Journal:  Molecules       Date:  2018-05-11       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.